Justin Bowers
Stock Analyst at Deutsche Bank
(1.87)
# 3,265
Out of 5,044 analysts
40
Total ratings
37.5%
Success rate
4.51%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $345.95 | -8.95% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $580.53 | -25.93% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $218.13 | +21.49% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $10.62 | +116.57% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $20.68 | +40.23% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $13.34 | +87.41% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $151.57 | +2.26% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $557.63 | +9.39% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $63.94 | +28.25% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $15.08 | +65.78% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.23 | +426.32% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $177.73 | +68.80% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $216.90 | +26.79% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $283.49 | -11.81% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $187.93 | +54.31% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $14.22 | +223.49% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $345.95
Upside: -8.95%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $580.53
Upside: -25.93%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $218.13
Upside: +21.49%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $10.62
Upside: +116.57%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $20.68
Upside: +40.23%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $13.34
Upside: +87.41%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $151.57
Upside: +2.26%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $557.63
Upside: +9.39%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $63.94
Upside: +28.25%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $15.08
Upside: +65.78%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.23
Upside: +426.32%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $177.73
Upside: +68.80%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $216.90
Upside: +26.79%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $283.49
Upside: -11.81%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $187.93
Upside: +54.31%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $14.22
Upside: +223.49%